메뉴 건너뛰기




Volumn 6, Issue 4, 2008, Pages 282-291

The role of Trimetazidine after acute myocardial Infarction

Author keywords

Acute coronary syndromes; Metabolic treatment; Trimetazidine

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; AMLODIPINE; ANTIANGINA PECTORIS AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARNITINE; CREATINE PHOSPHATE; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IVABRADINE; METOPROLOL; NICORANDIL; NIFEDIPINE; NITRATE; PERHEXILINE; PLACEBO; PROPIONYLCARNITINE; PROPRANOLOL; PYRUVATE DEHYDROGENASE; RANOLAZINE; TAURINE; TRIMETAZIDINE; UBIDECARENONE; UNINDEXED DRUG; CARDIOVASCULAR AGENT;

EID: 55449129959     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016108785909788     Document Type: Review
Times cited : (15)

References (62)
  • 1
    • 33846285411 scopus 로고    scopus 로고
    • NT-proBNP in patients after acute coronary syndrome with ST segment elevation subjected to early posthospitalization cardiologic rehabilitation
    • Irzmanski R, Piechota M, Barylski M, Banach M, Kowalski J, Serwa-Stepien E, et al. NT-proBNP in patients after acute coronary syndrome with ST segment elevation subjected to early posthospitalization cardiologic rehabilitation. Arch Med Sci 2006; 2: 262-267.
    • (2006) Arch Med Sci , vol.2 , pp. 262-267
    • Irzmanski, R.1    Piechota, M.2    Barylski, M.3    Banach, M.4    Kowalski, J.5    Serwa-Stepien, E.6
  • 3
    • 0036445726 scopus 로고    scopus 로고
    • Increase of adenosine plasma levels after oral trimetazidine: A pharmacological preconditioning?
    • Blardi P, de Lalla A, Volpi L, Auteri A, Di Perri T. Increase of adenosine plasma levels after oral trimetazidine: a pharmacological preconditioning? Pharmacol Res 2002; 45: 69-72.
    • (2002) Pharmacol Res , vol.45 , pp. 69-72
    • Blardi, P.1    de Lalla, A.2    Volpi, L.3    Auteri, A.4    Di Perri, T.5
  • 4
    • 34447523485 scopus 로고    scopus 로고
    • Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists?
    • Lopez N, Varo N, Diez J, Fortuno MA. Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists? Cardiovasc Res 2007; 75: 536-45.
    • (2007) Cardiovasc Res , vol.75 , pp. 536-545
    • Lopez, N.1    Varo, N.2    Diez, J.3    Fortuno, M.A.4
  • 6
    • 33750606896 scopus 로고    scopus 로고
    • Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention
    • Kowalski J, Barylski M, Banach M, Grycewicz J, Irzmanski R, Pawlicki L. Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention. J Cardiovasc Pharmacol 2006; 48: 143-7.
    • (2006) J Cardiovasc Pharmacol , vol.48 , pp. 143-147
    • Kowalski, J.1    Barylski, M.2    Banach, M.3    Grycewicz, J.4    Irzmanski, R.5    Pawlicki, L.6
  • 7
    • 0034678082 scopus 로고    scopus 로고
    • The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase
    • Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 2000; 86: 580-8.
    • (2000) Circ Res , vol.86 , pp. 580-588
    • Kantor, P.F.1    Lucien, A.2    Kozak, R.3    Lopaschuk, G.D.4
  • 8
    • 27644492930 scopus 로고    scopus 로고
    • Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury
    • Argaud L, Gomez L, Gateau-Roesch O, Couture-Lepetit E, Loufouat J, Robert D, et al. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury. J Mol Cell Cardiol 2005; 39: 893-999.
    • (2005) J Mol Cell Cardiol , vol.39 , pp. 893-999
    • Argaud, L.1    Gomez, L.2    Gateau-Roesch, O.3    Couture-Lepetit, E.4    Loufouat, J.5    Robert, D.6
  • 9
    • 3242810591 scopus 로고    scopus 로고
    • Anand I, McMurray J, Cohn JN, Konstam MA, Notter T, Quitzau K, et al.; EARTH investigators. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet2004; 364: 347-54.
    • Anand I, McMurray J, Cohn JN, Konstam MA, Notter T, Quitzau K, et al.; EARTH investigators. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet2004; 364: 347-54.
  • 10
    • 38549097298 scopus 로고    scopus 로고
    • The role of trimetazidine in inhibiting cardiomyocyte apoptosis
    • Ruixing Y. The role of trimetazidine in inhibiting cardiomyocyte apoptosis. Arch Med Sci 2007; 3: S17-S24.
    • (2007) Arch Med Sci , vol.3
    • Ruixing, Y.1
  • 11
    • 12844280008 scopus 로고    scopus 로고
    • Comparative efficacy of ranolazine vs. atenolol for chronic angina pectoris
    • Rousseau MF, Pouleur H, Cocco G, Wolff AA. Comparative efficacy of ranolazine vs. atenolol for chronic angina pectoris. Am J Cardiol 2005; 95: 311-6.
    • (2005) Am J Cardiol , vol.95 , pp. 311-316
    • Rousseau, M.F.1    Pouleur, H.2    Cocco, G.3    Wolff, A.A.4
  • 12
    • 34247526904 scopus 로고    scopus 로고
    • MERLIN-TIMI 36 Trial Investigators. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: The MERLIN-TIMI 36 randomized trial
    • Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, Murphy SA, Budaj A, Varshavsky S, et al. MERLIN-TIMI 36 Trial Investigators. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA 2007; 297: 1775-83.
    • (2007) JAMA , vol.297 , pp. 1775-1783
    • Morrow, D.A.1    Scirica, B.M.2    Karwatowska-Prokopczuk, E.3    Murphy, S.A.4    Budaj, A.5    Varshavsky, S.6
  • 13
    • 35148850168 scopus 로고    scopus 로고
    • Scirica BM, Morrow DA, Hod H, Murphy SA, Belardinelli L, Hedgepeth CM, et al. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLINTIMI 36) randomized controlled trial. Circulation 2007; 116: 1647-52.
    • Scirica BM, Morrow DA, Hod H, Murphy SA, Belardinelli L, Hedgepeth CM, et al. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLINTIMI 36) randomized controlled trial. Circulation 2007; 116: 1647-52.
  • 14
    • 0348129532 scopus 로고    scopus 로고
    • Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: A randomized controlled trial
    • Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, et al.; Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA 2004; 291(3): 309-16.
    • (2004) JAMA , vol.291 , Issue.3 , pp. 309-316
    • Chaitman, B.R.1    Pepine, C.J.2    Parker, J.O.3    Skopal, J.4    Chumakova, G.5    Kuch, J.6
  • 15
    • 11144356285 scopus 로고    scopus 로고
    • MARISA Investigators.Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina
    • Chaitman BR, Skettino SL, Parker JO, Hanley P, Meluzin J, Kuch J, et al. MARISA Investigators.Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol 2004; 43(8): 1375-82.
    • (2004) J Am Coll Cardiol , vol.43 , Issue.8 , pp. 1375-1382
    • Chaitman, B.R.1    Skettino, S.L.2    Parker, J.O.3    Hanley, P.4    Meluzin, J.5    Kuch, J.6
  • 16
    • 33746192571 scopus 로고    scopus 로고
    • ERICA Investigators. Antianginal efficacy of ranolazine when added to treatment with amlodipine: The ERICA (Efficacy of Ranolazine in Chronic Angina) trial
    • Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L; ERICA Investigators. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol 2006; 48(3): 566-75.
    • (2006) J Am Coll Cardiol , vol.48 , Issue.3 , pp. 566-575
    • Stone, P.H.1    Gratsiansky, N.A.2    Blokhin, A.3    Huang, I.Z.4    Meng, L.5
  • 17
    • 33646432742 scopus 로고    scopus 로고
    • Ranolazine and late cardiac sodium current - a therapeutic target for angina, arrythmia and more
    • Makielski JC, Valdivia CR. Ranolazine and late cardiac sodium current - a therapeutic target for angina, arrythmia and more. Brit J Pharmacol 2006; 148: 4-6.
    • (2006) Brit J Pharmacol , vol.148 , pp. 4-6
    • Makielski, J.C.1    Valdivia, C.R.2
  • 20
    • 38549147125 scopus 로고    scopus 로고
    • Metabolic management of diabetic patients with ischaemic heart disease
    • Caminiti G, Marazzi G, Vitale C, Rosano GMC. Metabolic management of diabetic patients with ischaemic heart disease. Arch Med Sci 2007; 3: S30-S37.
    • (2007) Arch Med Sci , vol.3
    • Caminiti, G.1    Marazzi, G.2    Vitale, C.3    Rosano, G.M.C.4
  • 21
    • 39449133618 scopus 로고    scopus 로고
    • The current role of statins in acute coronary syndrome
    • Kumar A, Cannon CP. The current role of statins in acute coronary syndrome. Arch Med Sci 2007; 3: S115-S125.
    • (2007) Arch Med Sci , vol.3
    • Kumar, A.1    Cannon, C.P.2
  • 23
    • 33750994335 scopus 로고    scopus 로고
    • Grupo de trabajo de la sociedad europea de cardiologia sobre el manejo de la angina estable. Guidelines on the management of stable angina pectoris. Executive summary
    • Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, et al. Grupo de trabajo de la sociedad europea de cardiologia sobre el manejo de la angina estable. Guidelines on the management of stable angina pectoris. Executive summary. Rev Esp Cardiol 2006; 59: 919-70.
    • (2006) Rev Esp Cardiol , vol.59 , pp. 919-970
    • Fox, K.1    Garcia, M.A.2    Ardissino, D.3    Buszman, P.4    Camici, P.G.5    Crea, F.6
  • 25
    • 33745683654 scopus 로고    scopus 로고
    • Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: Executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
    • Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, et al. Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27: 1341-1381.
    • (2006) Eur Heart J , vol.27 , pp. 1341-1381
    • Fox, K.1    Garcia, M.A.2    Ardissino, D.3    Buszman, P.4    Camici, P.G.5    Crea, F.6
  • 28
    • 0033036313 scopus 로고    scopus 로고
    • Szwed H, Sadowski Z, Pachocki R, Domza-Bochenska M, Szymczak K, Szydlowski Z, et al. The antiischemic effects and tolerability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1. Cardiovasc Drugs Ther1999; 13: 217-22.
    • Szwed H, Sadowski Z, Pachocki R, Domza-Bochenska M, Szymczak K, Szydlowski Z, et al. The antiischemic effects and tolerability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1. Cardiovasc Drugs Ther1999; 13: 217-22.
  • 29
    • 18244401979 scopus 로고    scopus 로고
    • Combination treatment in stable effort angina using trimetazidine and metoprolol: Results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand
    • Szwed H, Sadowski Z, Elikowski W, Koronkiewicz A, Mamcarz A, Orszulak W, et al. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand. Eur Heart J 2001; 22: 2267-74.
    • (2001) Eur Heart J , vol.22 , pp. 2267-2274
    • Szwed, H.1    Sadowski, Z.2    Elikowski, W.3    Koronkiewicz, A.4    Mamcarz, A.5    Orszulak, W.6
  • 30
    • 16244386878 scopus 로고    scopus 로고
    • A prospective study on trimetazidine effectiveness and tolerability in diabetic patients in association to the previous treatment of their coronary disease. DIETRIC study
    • Rodriguez Padial L, Maicas Bellido C, Velazquez Martin M, Gil Polo B. A prospective study on trimetazidine effectiveness and tolerability in diabetic patients in association to the previous treatment of their coronary disease. DIETRIC study. Rev Clin Esp 2005; 58: 57-62.
    • (2005) Rev Clin Esp , vol.58 , pp. 57-62
    • Rodriguez Padial, L.1    Maicas Bellido, C.2    Velazquez Martin, M.3    Gil Polo, B.4
  • 31
    • 18544408022 scopus 로고    scopus 로고
    • Effects of trimetazidine on submaximal exercise test in patients with acute myocardial infarction
    • Güler N, Eryonucu B, Günes A, Güntekin U, Tuncer M, Ozbek H. Effects of trimetazidine on submaximal exercise test in patients with acute myocardial infarction. Cardiovasc Drugs Ther. 2003; 17: 371-4.
    • (2003) Cardiovasc Drugs Ther , vol.17 , pp. 371-374
    • Güler, N.1    Eryonucu, B.2    Günes, A.3    Güntekin, U.4    Tuncer, M.5    Ozbek, H.6
  • 32
    • 0032564373 scopus 로고    scopus 로고
    • Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group
    • Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalán R, et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998; 98: 2227-34.
    • (1998) Circulation , vol.98 , pp. 2227-2234
    • Diaz, R.1    Paolasso, E.A.2    Piegas, L.S.3    Tajer, C.D.4    Moreno, M.G.5    Corvalán, R.6
  • 33
    • 0033817242 scopus 로고    scopus 로고
    • Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project - Free Radicals
    • Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project - Free Radicals. Eur Heart J 2000; 21: 1537-46.
    • (2000) Eur Heart J , vol.21 , pp. 1537-1546
  • 34
    • 26944485823 scopus 로고    scopus 로고
    • Vinten-Johansen J, Yellon DM, Opie LH. Postconditioning, a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation 2005; 112: 2085-88.
    • Vinten-Johansen J, Yellon DM, Opie LH. Postconditioning, a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation 2005; 112: 2085-88.
  • 35
    • 33750945444 scopus 로고    scopus 로고
    • L-arginine improves hemodynamic function and coronary flow in an experimental model of ischemia-reperfusion injury
    • Okonski P, Banach M, Rysz J, Barylski M, Irzmanski R, Piechota M, et al. L-arginine improves hemodynamic function and coronary flow in an experimental model of ischemia-reperfusion injury. Ann Transplant 2006; 11: 26-32.
    • (2006) Ann Transplant , vol.11 , pp. 26-32
    • Okonski, P.1    Banach, M.2    Rysz, J.3    Barylski, M.4    Irzmanski, R.5    Piechota, M.6
  • 37
    • 33747365277 scopus 로고    scopus 로고
    • Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with angina
    • Danchin N. Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with angina. Am J Cardiol 2006; 98: 8J-13J.
    • (2006) Am J Cardiol , vol.98
    • Danchin, N.1
  • 38
    • 33744995586 scopus 로고    scopus 로고
    • Effects of metabolic triad (25% polarizing solution, mildronat, preductal MR) in acute myocardial infarction
    • 131
    • Svanidze TD, Gorgoshidze ML, Tsintsadze IN, Glonti TG. Effects of metabolic triad (25% polarizing solution, mildronat, preductal MR) in acute myocardial infarction. Georgian Med News 2006; 131: 49-52.
    • (2006) Georgian Med News , pp. 49-52
    • Svanidze, T.D.1    Gorgoshidze, M.L.2    Tsintsadze, I.N.3    Glonti, T.G.4
  • 39
    • 46749156747 scopus 로고    scopus 로고
    • Clinical study of trimetazidine for myocardial protection in acute myocardial infarction
    • Dong XD, Hu DY, Jia SQ, Wang L, Yan SB.Clinical study of trimetazidine for myocardial protection in acute myocardial infarction. Zhonghua Nei Ke Za Zhi 2007; 46: 633-6.
    • (2007) Zhonghua Nei Ke Za Zhi , vol.46 , pp. 633-636
    • Dong, X.D.1    Hu, D.Y.2    Jia, S.Q.3    Wang, L.4    Yan, S.B.5
  • 40
    • 0035134803 scopus 로고    scopus 로고
    • A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction
    • for the LIST Study Group
    • Steg PG, Grollier G, Gallay P, Morice M, Karrillon GJ, Benamer H, et al. for the LIST Study Group. A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction. Int J Cardiol 2001; 77: 263-273
    • (2001) Int J Cardiol , vol.77 , pp. 263-273
    • Steg, P.G.1    Grollier, G.2    Gallay, P.3    Morice, M.4    Karrillon, G.J.5    Benamer, H.6
  • 41
    • 0036449297 scopus 로고    scopus 로고
    • Trimetazidine limits the effects of myocardial ischaemia during percutaneous coronary angioplasty
    • Polonski L., Dec I. Wojnar R, Wilczek K. Trimetazidine limits the effects of myocardial ischaemia during percutaneous coronary angioplasty. Curr Med Res Opin 2002; 18: 389-394.
    • (2002) Curr Med Res Opin , vol.18 , pp. 389-394
    • Polonski, L.1    Dec, I.2    Wojnar, R.3    Wilczek, K.4
  • 42
    • 0030957232 scopus 로고    scopus 로고
    • Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty
    • Birand A, Kudaiberdieva GZ, Batyraliev TA, Akgul F, Usal A. Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty. Angiology 1997; 48: 413-22.
    • (1997) Angiology , vol.48 , pp. 413-422
    • Birand, A.1    Kudaiberdieva, G.Z.2    Batyraliev, T.A.3    Akgul, F.4    Usal, A.5
  • 43
    • 0026699975 scopus 로고
    • Myocardial protection during percutaneous transluminal coronary angioplasty: Effects of trimetazidine
    • Kober G, Buck T, Sievert H, Vallbracht C. Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine. Eur Heart J 1992; 13: 1109-15.
    • (1992) Eur Heart J , vol.13 , pp. 1109-1115
    • Kober, G.1    Buck, T.2    Sievert, H.3    Vallbracht, C.4
  • 44
  • 45
    • 33644542154 scopus 로고    scopus 로고
    • Suppression of angioplasty-related inflammation by pre-procedural treatment with trimetazidine
    • Kuralay F, Altekin E, Yazlar AS, Onvural B, Goldeli O. Suppression of angioplasty-related inflammation by pre-procedural treatment with trimetazidine. Tohoku J Exp Med 2006; 208: 203-12.
    • (2006) Tohoku J Exp Med , vol.208 , pp. 203-212
    • Kuralay, F.1    Altekin, E.2    Yazlar, A.S.3    Onvural, B.4    Goldeli, O.5
  • 46
    • 34249283806 scopus 로고    scopus 로고
    • Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention
    • Bonello L, Sbragia P, Amabile N, Com O, Pierre SV, Levy S, et al. Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention. Heart 2007; 93: 703-7.
    • (2007) Heart , vol.93 , pp. 703-707
    • Bonello, L.1    Sbragia, P.2    Amabile, N.3    Com, O.4    Pierre, S.V.5    Levy, S.6
  • 47
    • 39449108558 scopus 로고    scopus 로고
    • von Haehling S, Anker S. Statins for heart failure: where to go from here? Arch Med Sci 2007; 3: S133-S141.
    • von Haehling S, Anker S. Statins for heart failure: where to go from here? Arch Med Sci 2007; 3: S133-S141.
  • 49
    • 0034503715 scopus 로고    scopus 로고
    • Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy
    • Belardinelli R. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy. Rev Port Cardiol 2000; 19: V35-9.
    • (2000) Rev Port Cardiol , vol.19
    • Belardinelli, R.1
  • 50
    • 0032189888 scopus 로고    scopus 로고
    • Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease
    • Lu C, Dabrowski P, Fragasso G, Chierchia SL. Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease. Am J Cardiol. 1998; 82: 898-901.
    • (1998) Am J Cardiol , vol.82 , pp. 898-901
    • Lu, C.1    Dabrowski, P.2    Fragasso, G.3    Chierchia, S.L.4
  • 51
    • 1542496389 scopus 로고    scopus 로고
    • Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy
    • Fragasso G, Piatti Md PM, HMonti LH, Palloshi A, Setola E, Puccetti P, et al. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy. Am Heart J 2003; 146(5): E18-E25.
    • (2003) Am Heart J , vol.146 , Issue.5
    • Fragasso, G.1    Piatti, M.P.2    HMonti, L.H.3    Palloshi, A.4    Setola, E.5    Puccetti, P.6
  • 52
    • 0035208524 scopus 로고    scopus 로고
    • Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy
    • Belardinelli R, Purcaro A. Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy. Eur Heart J 2001; 22: 2164-2170.
    • (2001) Eur Heart J , vol.22 , pp. 2164-2170
    • Belardinelli, R.1    Purcaro, A.2
  • 53
    • 22244463240 scopus 로고    scopus 로고
    • Effects of trimetazidine on myocardial perfusion and the contractile response of chronically dysfunctional myocardium in ischemic cardiomyopathy: A 24-month study
    • El-Kady T, El-Sabban K, Gabaly M, Sabry A, Abdel-Hady S. Effects of trimetazidine on myocardial perfusion and the contractile response of chronically dysfunctional myocardium in ischemic cardiomyopathy: a 24-month study. Am J Cardiovasc Drugs 2005; 5: 271-8.
    • (2005) Am J Cardiovasc Drugs , vol.5 , pp. 271-278
    • El-Kady, T.1    El-Sabban, K.2    Gabaly, M.3    Sabry, A.4    Abdel-Hady, S.5
  • 54
    • 34249001974 scopus 로고    scopus 로고
    • Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention
    • Labrou A, Giannoglou G, Zioutas D, Fragakis N, Katsaris G, Louridas G. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention. Am J Cardiovasc Drugs 2007; 7(2): 143-50.
    • (2007) Am J Cardiovasc Drugs , vol.7 , Issue.2 , pp. 143-150
    • Labrou, A.1    Giannoglou, G.2    Zioutas, D.3    Fragakis, N.4    Katsaris, G.5    Louridas, G.6
  • 55
    • 12744261465 scopus 로고    scopus 로고
    • Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy
    • Di Napoli P, Taccardi AA, Barsotti A. Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy. Heart 2005; 91: 161-5.
    • (2005) Heart , vol.91 , pp. 161-165
    • Di Napoli, P.1    Taccardi, A.A.2    Barsotti, A.3
  • 57
    • 38549115290 scopus 로고    scopus 로고
    • Refractory angina - current therapeutic challenge
    • Szwed H, Dabrowski R. Refractory angina - current therapeutic challenge. Arch Med Sci 2007; 3: S38-S44.
    • (2007) Arch Med Sci , vol.3
    • Szwed, H.1    Dabrowski, R.2
  • 58
    • 33747887613 scopus 로고    scopus 로고
    • A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure
    • Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, et al. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. J Am Coll Cardiol 2006; 48: 992-8.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 992-998
    • Fragasso, G.1    Palloshi, A.2    Puccetti, P.3    Silipigni, C.4    Rossodivita, A.5    Pala, M.6
  • 59
    • 34547777411 scopus 로고    scopus 로고
    • Nowak MS, Wybór K, Gos R, Zeman-Miecznik A, Waszczykowska A, Pastuszkaet M al. Protective effect on visual functions of long-term use of trimetazidine in treatment of primary open angle glaucoma and degenerative myopia. Arch Med Sci 2007; 3: 152-156.
    • Nowak MS, Wybór K, Gos R, Zeman-Miecznik A, Waszczykowska A, Pastuszkaet M al. Protective effect on visual functions of long-term use of trimetazidine in treatment of primary open angle glaucoma and degenerative myopia. Arch Med Sci 2007; 3: 152-156.
  • 61
    • 34547794180 scopus 로고    scopus 로고
    • Weight reduction decreases NT-proBNP levels in obsese coronary patients with chronic diastolic heart failure
    • Cocco G, Chu D. Weight reduction decreases NT-proBNP levels in obsese coronary patients with chronic diastolic heart failure. Arch Med Sci 2007; 3: 112-116.
    • (2007) Arch Med Sci , vol.3 , pp. 112-116
    • Cocco, G.1    Chu, D.2
  • 62
    • 44149098471 scopus 로고    scopus 로고
    • Statins in the prevention of postoperative atrial fibrillation: Is there really no effect?
    • Banach M, Goch JH, Ugurlucan M, Mariscalco G, Rysz J. Statins in the prevention of postoperative atrial fibrillation: is there really no effect? Am Heart J 2008; 155(6): e53
    • (2008) Am Heart J , vol.155 , Issue.6
    • Banach, M.1    Goch, J.H.2    Ugurlucan, M.3    Mariscalco, G.4    Rysz, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.